endometrial cancer
Conditions
Interventions
Case series:Specific sensitive drug therapy for patients with endometrial cancer based on in vitro cultured organs
Sponsors
Shanghai Tenth People's Hospital, Tongji University
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) The patient is between 18-70 years old; (2) Endometrial diagnostic curettage pathology suggests endometrioid adenocarcinoma (including Bokman type I and II); (3) Signing informed consent and Ability to comply with follow-up actions.
Exclusion criteria
Exclusion criteria: (1) pregnant women; (2) those with other malignant tumors (such as cervical cancer, fallopian tube cancer, ovarian cancer, etc.); (3) those who have undergone other special types of treatment within the first half of the experiment: such as radiotherapy and chemotherapy, progesterone therapy, etc.; (4) Those who have combined with systemic immune diseases (such as rheumatic immune diseases, systemic lupus erythematosus, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| progression free survival, PFS;Overall survival, OS; | — |
Secondary
| Measure | Time frame |
|---|---|
| imageological examination;Objective response rate, ORR; | — |
Countries
China
Contacts
Public ContactZhongping Cheng
Shanghai Tenth People's Hospital, Tongji University
Outcome results
None listed